Neoantigen Targeted Therapies Market - Current Impact to Make Big Changes by 2035
Cancer immunotherapy is increasingly moving toward treatments tailored to the molecular characteristics of individual tumors. Neoantigens, which arise from tumor-specific mutations, provide potential targets that can distinguish cancer cells from healthy tissue.

For more information on the Neoantigen Targeted Therapies Market, visit:

https://www.rootsanalysis.com/....reports/neoantigen-t

Neoantigen Targeted Therapies Market Size & Trends, 2030

Global neoantigen targeted therapies market is expected to grow from $661 million in 2025 to $807 million in 2026 and $2,913 billion by 2030, at a CAGR of 38%.